BioLine Rx Ltd (BLRX)
0.3232
-0.22
(-40.71%)
USD |
NASDAQ |
Nov 21, 16:00
0.32
0.00 (0.00%)
Pre-Market: 08:14
BioLine Rx EPS Diluted (Quarterly): 0.0061 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0061 |
| March 31, 2024 | -0.0096 |
| December 31, 2023 | -0.15 |
| September 30, 2023 | -0.30 |
| June 30, 2023 | -0.30 |
| March 31, 2023 | -0.15 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.15 |
| June 30, 2022 | -0.15 |
| March 31, 2022 | -0.15 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.15 |
| June 30, 2021 | -0.15 |
| March 31, 2021 | -0.30 |
| December 31, 2020 | -0.60 |
| September 30, 2020 | -0.30 |
| June 30, 2020 | -0.45 |
| March 31, 2020 | -0.60 |
| December 31, 2019 | -0.90 |
| September 30, 2019 | -0.45 |
| June 30, 2019 | -0.60 |
| March 31, 2019 | -0.75 |
| December 31, 2018 | -0.75 |
| September 30, 2018 | -0.90 |
| June 30, 2018 | -0.75 |
| Date | Value |
|---|---|
| March 31, 2018 | -0.90 |
| December 31, 2017 | -1.05 |
| September 30, 2017 | -1.05 |
| June 30, 2017 | -0.75 |
| March 31, 2017 | -1.20 |
| December 31, 2016 | -1.05 |
| September 30, 2016 | -1.20 |
| June 30, 2016 | -1.05 |
| March 31, 2016 | -0.90 |
| December 31, 2015 | -1.05 |
| September 30, 2015 | -0.45 |
| June 30, 2015 | -1.35 |
| March 31, 2015 | -1.515 |
| December 31, 2014 | -1.80 |
| September 30, 2014 | -0.30 |
| June 30, 2014 | -1.80 |
| March 31, 2014 | -1.20 |
| December 31, 2013 | -2.614 |
| September 30, 2013 | -3.237 |
| June 30, 2013 | -2.837 |
| March 31, 2013 | -2.463 |
| December 31, 2012 | -6.263 |
| September 30, 2012 | -4.950 |
| June 30, 2012 | -2.300 |
| March 31, 2012 | -4.845 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.90
Minimum
Dec 2019
0.0061
Maximum
Jun 2024
-0.2528
Average
-0.15
Median
Jun 2021
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd | 0.01 |
| Pluri Inc | -1.08 |
| XTL Biopharmaceuticals Ltd | 0.10 |
| Can Fite Biofarma Ltd | -1.517 |
| BiomX Inc | 0.31 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.484M |
| Revenue (Quarterly) | 5.393M |
| Total Expenses (Quarterly) | 11.17M |
| Enterprise Value | 15.23M |
| Gross Profit Margin (Quarterly) | 83.37% |
| Profit Margin (Quarterly) | 8.97% |
| Earnings Yield | -140.3% |